Prim, S.A. (BME:PRM)
Spain · Delayed Price · Currency is EUR 13.90
+0.05 (0.36%)
Dec 5, 2025, 10:22 AM CET
Prim, S.A. Market Cap
Prim, S.A. has a market cap or net worth of €235.67 million as of December 5, 2025. Its market cap has increased by 38.78% in one year.
Market Cap
235.67M
Enterprise Value
239.30M
Revenue
240.68M
Ranking
n/a
PE Ratio
16.29
Stock Price
€13.90
Market Cap Chart
Since March 2, 1998, Prim, S.A.'s market cap has increased from 7.51M to 235.67M, an increase of 3,039.65%. That is a compound annual growth rate of 13.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 235.67M | 43.97% |
| Dec 31, 2024 | 163.70M | -7.91% |
| Dec 29, 2023 | 177.76M | -3.62% |
| Dec 30, 2022 | 184.45M | -26.55% |
| Dec 30, 2021 | 251.13M | 49.42% |
| Dec 31, 2020 | 168.06M | -15.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.36B |
| Laboratorios Farmaceuticos Rovi | 3.03B |
| Almirall | 2.73B |
| Faes Farma | 1.48B |
| Pharma Mar | 1.25B |
| Clínica Baviera | 754.17M |
| Oryzon Genomics | 250.75M |
| Laboratorio Reig Jofre | 222.20M |